Questionnaire survey to clinical trial sponsors on the management organization of information on adverse events

Hiroyuki Furukawa, Masahiro Uchikata, Yukiko Matsushima, Sachie Osada, Eiko Yokoyama, Shizue Matsuda, Junko Ishizaki, Sakae Shimizu, Hisashi Bunko, Ken'ichi Miyamoto

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

In order to examine the efficient management method of the vast amount of information on adverse events, a questionnaire survey on the evaluation organization of adverse events in a clinical trial and the implementation of information technology for information management was given to 50 clinical trial sponsors. Of the sponsors, 64% has a evaluation criteria for the causal relationship of an investigational drug and adverse events, but the 84% is "internal original standard". With 56% of sponsors, a doctor permanently resides to perform causal relationship evaluation, and 44% of sponsors rely on "outsourcing". All sponsors with no permanent residence doctor and no evaluation criteria are Japanese companies. A delay in maintenance in information management organization, including the holding frequency of the evaluation committee, was observed in Japanese sponsor. Among sponsors, 88% replied that it would be useful to create a database of adverse events, presuming that sponsors can correspond with front electric formal data. However, the sponsors do not wish to meet the request from each individual institution, rather they want to offer by standard format; both the sponsor and the institution need to agree on standard data items.

Original languageEnglish
Pages (from-to)281-286
Number of pages6
JournalJapanese Journal of Clinical Pharmacology and Therapeutics
Volume33
Issue number6
Publication statusPublished - 2002 Nov
Externally publishedYes

Fingerprint

Information Management
Clinical Trials
Organizations
Outsourced Services
Investigational Drugs
Maintenance
Surveys and Questionnaires
Databases
Technology

Keywords

  • Adverse event
  • Clinical trial sponsor
  • Database
  • Evaluation criteria
  • Information technology

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Furukawa, H., Uchikata, M., Matsushima, Y., Osada, S., Yokoyama, E., Matsuda, S., ... Miyamoto, K. (2002). Questionnaire survey to clinical trial sponsors on the management organization of information on adverse events. Japanese Journal of Clinical Pharmacology and Therapeutics, 33(6), 281-286.

Questionnaire survey to clinical trial sponsors on the management organization of information on adverse events. / Furukawa, Hiroyuki; Uchikata, Masahiro; Matsushima, Yukiko; Osada, Sachie; Yokoyama, Eiko; Matsuda, Shizue; Ishizaki, Junko; Shimizu, Sakae; Bunko, Hisashi; Miyamoto, Ken'ichi.

In: Japanese Journal of Clinical Pharmacology and Therapeutics, Vol. 33, No. 6, 11.2002, p. 281-286.

Research output: Contribution to journalArticle

Furukawa, H, Uchikata, M, Matsushima, Y, Osada, S, Yokoyama, E, Matsuda, S, Ishizaki, J, Shimizu, S, Bunko, H & Miyamoto, K 2002, 'Questionnaire survey to clinical trial sponsors on the management organization of information on adverse events', Japanese Journal of Clinical Pharmacology and Therapeutics, vol. 33, no. 6, pp. 281-286.
Furukawa, Hiroyuki ; Uchikata, Masahiro ; Matsushima, Yukiko ; Osada, Sachie ; Yokoyama, Eiko ; Matsuda, Shizue ; Ishizaki, Junko ; Shimizu, Sakae ; Bunko, Hisashi ; Miyamoto, Ken'ichi. / Questionnaire survey to clinical trial sponsors on the management organization of information on adverse events. In: Japanese Journal of Clinical Pharmacology and Therapeutics. 2002 ; Vol. 33, No. 6. pp. 281-286.
@article{edaae46e09dd424c842c8d2b7ccdc6a0,
title = "Questionnaire survey to clinical trial sponsors on the management organization of information on adverse events",
abstract = "In order to examine the efficient management method of the vast amount of information on adverse events, a questionnaire survey on the evaluation organization of adverse events in a clinical trial and the implementation of information technology for information management was given to 50 clinical trial sponsors. Of the sponsors, 64{\%} has a evaluation criteria for the causal relationship of an investigational drug and adverse events, but the 84{\%} is {"}internal original standard{"}. With 56{\%} of sponsors, a doctor permanently resides to perform causal relationship evaluation, and 44{\%} of sponsors rely on {"}outsourcing{"}. All sponsors with no permanent residence doctor and no evaluation criteria are Japanese companies. A delay in maintenance in information management organization, including the holding frequency of the evaluation committee, was observed in Japanese sponsor. Among sponsors, 88{\%} replied that it would be useful to create a database of adverse events, presuming that sponsors can correspond with front electric formal data. However, the sponsors do not wish to meet the request from each individual institution, rather they want to offer by standard format; both the sponsor and the institution need to agree on standard data items.",
keywords = "Adverse event, Clinical trial sponsor, Database, Evaluation criteria, Information technology",
author = "Hiroyuki Furukawa and Masahiro Uchikata and Yukiko Matsushima and Sachie Osada and Eiko Yokoyama and Shizue Matsuda and Junko Ishizaki and Sakae Shimizu and Hisashi Bunko and Ken'ichi Miyamoto",
year = "2002",
month = "11",
language = "English",
volume = "33",
pages = "281--286",
journal = "Japanese Journal of Clinical Pharmacology and Therapeutics",
issn = "0388-1601",
publisher = "Japanese Society of Clinical Pharmacology and Therapeutics",
number = "6",

}

TY - JOUR

T1 - Questionnaire survey to clinical trial sponsors on the management organization of information on adverse events

AU - Furukawa, Hiroyuki

AU - Uchikata, Masahiro

AU - Matsushima, Yukiko

AU - Osada, Sachie

AU - Yokoyama, Eiko

AU - Matsuda, Shizue

AU - Ishizaki, Junko

AU - Shimizu, Sakae

AU - Bunko, Hisashi

AU - Miyamoto, Ken'ichi

PY - 2002/11

Y1 - 2002/11

N2 - In order to examine the efficient management method of the vast amount of information on adverse events, a questionnaire survey on the evaluation organization of adverse events in a clinical trial and the implementation of information technology for information management was given to 50 clinical trial sponsors. Of the sponsors, 64% has a evaluation criteria for the causal relationship of an investigational drug and adverse events, but the 84% is "internal original standard". With 56% of sponsors, a doctor permanently resides to perform causal relationship evaluation, and 44% of sponsors rely on "outsourcing". All sponsors with no permanent residence doctor and no evaluation criteria are Japanese companies. A delay in maintenance in information management organization, including the holding frequency of the evaluation committee, was observed in Japanese sponsor. Among sponsors, 88% replied that it would be useful to create a database of adverse events, presuming that sponsors can correspond with front electric formal data. However, the sponsors do not wish to meet the request from each individual institution, rather they want to offer by standard format; both the sponsor and the institution need to agree on standard data items.

AB - In order to examine the efficient management method of the vast amount of information on adverse events, a questionnaire survey on the evaluation organization of adverse events in a clinical trial and the implementation of information technology for information management was given to 50 clinical trial sponsors. Of the sponsors, 64% has a evaluation criteria for the causal relationship of an investigational drug and adverse events, but the 84% is "internal original standard". With 56% of sponsors, a doctor permanently resides to perform causal relationship evaluation, and 44% of sponsors rely on "outsourcing". All sponsors with no permanent residence doctor and no evaluation criteria are Japanese companies. A delay in maintenance in information management organization, including the holding frequency of the evaluation committee, was observed in Japanese sponsor. Among sponsors, 88% replied that it would be useful to create a database of adverse events, presuming that sponsors can correspond with front electric formal data. However, the sponsors do not wish to meet the request from each individual institution, rather they want to offer by standard format; both the sponsor and the institution need to agree on standard data items.

KW - Adverse event

KW - Clinical trial sponsor

KW - Database

KW - Evaluation criteria

KW - Information technology

UR - http://www.scopus.com/inward/record.url?scp=0036879916&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036879916&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0036879916

VL - 33

SP - 281

EP - 286

JO - Japanese Journal of Clinical Pharmacology and Therapeutics

JF - Japanese Journal of Clinical Pharmacology and Therapeutics

SN - 0388-1601

IS - 6

ER -